Healthcare provider profile · identity verified

Harvey E Anderson, M.D.

Family Practice · BRAINERD, MN · NPI 1467655308

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1050	287
Amlodipine Besylate	Amlodipine Besylate	440	131
Lisinopril	Lisinopril	376	99
Omeprazole	Omeprazole	347	89
Hydrochlorothiazide	Hydrochlorothiazide	310	83
Losartan Potassium	Losartan Potassium	306	78
Metoprolol Succinate	Metoprolol Succinate	276	76
Levothyroxine Sodium	Levothyroxine Sodium	250	55
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	230	68
Rosuvastatin Calcium	Rosuvastatin Calcium	229	63
Tamsulosin Hcl	Tamsulosin Hcl	200	54
Metformin Hcl	Metformin Hcl	196	49
Gabapentin	Gabapentin	195	52
Simvastatin	Simvastatin	189	53
Metformin Hcl Er	Metformin Hcl	175	44
Warfarin Sodium	Warfarin Sodium	135	33
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	129	32
Allopurinol	Allopurinol	122	28
Alendronate Sodium	Alendronate Sodium	119	33
Jardiance	Empagliflozin	114	23
Trazodone Hcl	Trazodone Hcl	100	32
Pantoprazole Sodium	Pantoprazole Sodium	92	22
Duloxetine Hcl	Duloxetine Hcl	89	19
Sertraline Hcl	Sertraline Hcl	88	30
Pravastatin Sodium	Pravastatin Sodium	87	21
Eliquis	Apixaban	84	22
Ventolin Hfa	Albuterol Sulfate	84	29
Prednisone	Prednisone	82	68
Atenolol	Atenolol	80	21
Metoprolol Tartrate	Metoprolol Tartrate	80	23
Carvedilol	Carvedilol	77	21
Trulicity	Dulaglutide	75	suppressed
Ozempic	Semaglutide	67	11
Furosemide	Furosemide	66	26
Hydroxyzine Hcl	Hydroxyzine Hcl	65	19
Potassium Chloride	Potassium Chloride	64	19
Xarelto	Rivaroxaban	63	18
Citalopram Hbr	Citalopram Hydrobromide	61	21
Clopidogrel	Clopidogrel Bisulfate	54	13
Ezetimibe	Ezetimibe	54	22
Fluticasone Propionate	Fluticasone Propionate	52	15
Fluoxetine Hcl	Fluoxetine Hcl	51	14
Bupropion Xl	Bupropion Hcl	50	14
Topiramate	Topiramate	48	suppressed
Pregabalin	Pregabalin	47	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	46	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	suppressed
Montelukast Sodium	Montelukast Sodium	41	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	39	24
Pioglitazone Hcl	Pioglitazone Hcl	39	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	37	suppressed
Chlorthalidone	Chlorthalidone	37	11
Meloxicam	Meloxicam	37	11
Triamcinolone Acetonide	Triamcinolone Acetonide	36	29
Escitalopram Oxalate	Escitalopram Oxalate	34	12
Famotidine	Famotidine	33	suppressed
Finasteride	Finasteride	33	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	19
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	30	suppressed
Clonazepam	Clonazepam	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Glipizide Er	Glipizide	27	11
Zolpidem Tartrate	Zolpidem Tartrate	27	11
Ipratropium Bromide	Ipratropium Bromide	25	suppressed
Primidone	Primidone	25	suppressed
Loperamide	Loperamide Hcl	24	suppressed
Glipizide	Glipizide	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Restasis	Cyclosporine	22	suppressed
Salsalate	Salsalate	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Glimepiride	Glimepiride	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	19
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Azithromycin	Azithromycin	18	18
Baclofen	Baclofen	18	12
Colchicine	Colchicine	17	suppressed
Digoxin	Digoxin	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	16
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	12
Doxycycline Monohydrate	Doxycycline Monohydrate	15	14
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Amoxicillin	Amoxicillin	13	13
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	13	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	13	suppressed
Victoza 3-Pak	Liraglutide	13	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Nystatin	Nystatin	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Soliqua 100-33	Insulin Glargine/Lixisenatide	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error